🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label, single arm, prospective, and pilot study. Eligible p...
Status
Completed
Location
Chang Gung Medical Foundation
Start Date
2021-05-23
Trial ID
NCT04988750
Treatments Being Tested
Approximately 50% of patients with neuroendocrine cancers present with meta...
Status
Completed
Location
Odette Cancer Centre, Sunnybrook Health Science Centre
Start Date
2016-03
Trial ID
NCT02205515
Treatments Being Tested
This phase I trial studies the side effects and best dose of ropidoxuridine...
Status
Active Not Recruiting
Location
Rhode Island Hospital
Start Date
2016-02-01
Trial ID
NCT02381561
This phase I trial studies the side effects and best dose of hydroxychloroq...
Status
Terminated
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2011-08
Trial ID
NCT01417403
Treatments Being Tested
The purpose of this study is to investigate the effect of the adminstration...
Status
Completed
Location
Maastircht Radiation Oncology
Start Date
2003-05
Trial ID
NCT00181532
Treatments Being Tested
This is a single-centre, single-arm open-label proof-of-concept study to an...
Status
Completed
Location
Sunnybrook Health Sciences Centre
Start Date
2012-03
Trial ID
NCT01569984
Treatments Being Tested
RATIONALE: Gefitinib may stop the growth of tumor cells by blocking some of...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00268255
Phase I trial to study the effectiveness of topotecan and radiation therapy...
Status
Completed
Location
University of Wisconsin Comprehensive Cancer Center
Start Date
1995-03
Trial ID
NCT00002625
Treatments Being Tested
Our preclinical study confirmed that copper accumulation can lead to radior...
Status
Unknown
Location
Southern medical university
Start Date
2023-11-15
Trial ID
NCT06103617
Treatments Being Tested
This is an open-label, non-randomized, combination study of cetuximab, gemc...
Status
Completed
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00424827
Treatments Being Tested